The company usually posts poor financials for mid or long term investments.
The company has poor fundamentals for a short-term investment strategy.
Strengths
The company is one of the most undervalued, with an "enterprise value to sales" ratio at 520.38 for the 2020 fiscal year.
Analysts covering this company mostly recommend stock overweighting or purchase.
Weaknesses
Stock prices approach a strong long-term resistance in weekly data at KRW 120500.
According to forecast, a sluggish sales growth is expected for the next fiscal years.
The company has insufficient levels of profitability.
Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
With an expected P/E ratio at 70.38 and 40.11 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
The company is not the most generous with respect to shareholders' compensation.
For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.
For the past seven days, analysts have been lowering their EPS expectations for the company.
For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
For the past year, analysts have significantly revised downwards their profit estimates.